Finance

Lists
Why is QNTM down 4.94%?
Dive Deeper
QNTM:NASDAQ
Quantum Biopharma Ltd
$3.27
-4.94%
(-0.17) 1D
$3.26
-0.27% (-0.0087)
After hours
Closed: Oct 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNTM...
Open
$3.40
High
$3.49
Low
$3.25
Mkt. cap
26.91M
Avg. vol.
173.12K
Volume
244.16K
52-wk high
$18.87
52-wk low
$2.07
EPS
-$5.70
Beta
0.39
Shares outstanding
8.09M
No. of employees
17
Open
$3.40
High
$3.49
Low
$3.25
Mkt. cap
26.91M
Avg. vol.
173.12K
Volume
244.16K
52-wk high
$18.87
52-wk low
$2.07
EPS
-$5.70
Beta
0.39
Shares outstanding
8.09M
No. of employees
17
News stories
From web sources and news partners
About Quantum Biopharma Ltd
CEO-
Employees17
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitequantumbiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to QNTM in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for QNTM in the last 3 months
Highest
Current $3.27
$8.00 (+144.65%)
Average
$8.00 (+144.65%)
Lowest
$8.00 (+144.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael King
Rodman & Renshaw
Buy
Initiated
$8.00
+144.6%
08/31/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
495.22K
70.40K
626.09K
387.43K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.04M
1.37M
1.32M
1.76M
Operating expense
4.68M
2.37M
2.97M
2.29M
Total operating expenses
4.68M
2.37M
2.97M
2.29M
Operating income
-4.68M
-2.37M
-2.97M
-2.29M
Other non operating income
-222.38K
-2.48M
-10.47M
-972.01K
EBT including unusual items
-4.75M
-3.70M
-13.75M
-3.09M
EBT excluding unusual items
-4.91M
-6.29M
-13.48M
-3.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.32M
-3.03M
-13.56M
-3.25M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
100.42K
-
-
-
Interest expense
-105.08K
-1.44M
-45.18K
-239.16K
Net interest expenses
-4.66K
-1.44M
-45.18K
-239.16K
Depreciation and amortization charges
145.34K
129.37K
127.44K
128.37K
EBITDA
-4.53M
-2.24M
-2.84M
-2.17M
Gain or loss from assets sale
-
117.14K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps